Abstract
Six-monthly blood monitoring is frequently carried out for patients prescribed biological therapy for psoriasis in the UK. Through the analysis of blood results from a cohort of such patients, we demonstrated that a more targeted and coordinated approach to blood monitoring could be implemented, which would subsequently reduce carbon emissions, associated healthcare costs and the impact on patients’ employment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
